Literature DB >> 17639428

Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits.

Thomas G Beach1, Lucia I Sue, Douglas G Walker, Lih Fen Lue, Donald J Connor, John N Caviness, Marwan N Sabbagh, Charles H Adler.   

Abstract

Multiple reports have documented an age-related loss, estimated at about 10% per decade, of the pigmented neurons in the substantia nigra. This is associated with motor dysfunction, including bradykinesia, stooped posture and gait disturbance. As microglia are activated by cell death and neuromelanin pigment, we hypothesized that there should be a significant microglial reaction in normal aging human substantia nigra. Sections of substantia nigra from elderly subjects (N = 15; mean 81.3; SD 7.0) and younger subjects (N = 7; mean 30.3; SD = 8.7), all of which had no specific neurologically or neuropathologically defined disorders, were stained immunohistochemically for MHC Class II and the area occupied by microglia was quantified in substantia nigra pars compacta. All elderly subjects showed a pronounced microglial reaction in the substantia nigra, with frequent, intensely stained hypertrophic microglia, while immunoreactive nigral microglia were much less frequent in the younger subjects. Quantification showed that in older subjects, the percentage of substantia nigra area occupied by microglial bodies and processes was significantly greater than for younger subjects (mean 19.6 vs. 3.6; P = 0.005). Extraneuronal neuromelanin deposits were present in all the older subjects but were absent or rare in the younger subjects. The neuromelanin deposit abundance score in the older subjects correlated significantly with the area occupied by immunoreactive microglia. The marked microglial reaction in normal aging human substantia nigra, together with the previously reported 35-80% pigmented neuron loss, indicates the presence of a powerful pathologic process that may be additive with specific age-related neurodegenerative diseases, including Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17639428     DOI: 10.1007/s00401-007-0250-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  33 in total

Review 1.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

Review 2.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

3.  Differential neuroprotective and anti-inflammatory effects of L-type voltage dependent calcium channel and ryanodine receptor antagonists in the substantia nigra and locus coeruleus.

Authors:  Sarah C Hopp; Sarah E Royer; Heather M D'Angelo; Roxanne M Kaercher; David A Fisher; Gary L Wenk
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-16       Impact factor: 4.147

Review 4.  Estrogens, Neuroinflammation, and Neurodegeneration.

Authors:  Alessandro Villa; Elisabetta Vegeto; Angelo Poletti; Adriana Maggi
Journal:  Endocr Rev       Date:  2016-05-19       Impact factor: 19.871

5.  HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific.

Authors:  Douglas R Miller; Fatemeh Shaerzadeh; Leah Phan; Nesrin Sharif; Joyonna Gamble-George; Jay P McLaughlin; Wolfgang J Streit; Habibeh Khoshbouei
Journal:  Glia       Date:  2018-05-07       Impact factor: 7.452

6.  Neuromelanin inhibits CXCL10 expression in human astroglial cells.

Authors:  Neda Saffarian Tousi; Daniel J Buck; Luigi Zecca; Randall L Davis
Journal:  Neurosci Lett       Date:  2010-09-17       Impact factor: 3.046

7.  Microglia in the aging brain: relevance to neurodegeneration.

Authors:  Xiao-Guang Luo; Jian-Qing Ding; Sheng-Di Chen
Journal:  Mol Neurodegener       Date:  2010-03-24       Impact factor: 14.195

8.  Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.

Authors:  Anna L Bartels; Klaus L Leenders
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

Review 9.  Dopamine and aging: intersecting facets.

Authors:  C David Rollo
Journal:  Neurochem Res       Date:  2008-10-08       Impact factor: 3.996

10.  Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum.

Authors:  Daniel T Ohm; Claire Peterson; Rebecca Lobrovich; Katheryn A Q Cousins; Garrett S Gibbons; Corey T McMillan; David A Wolk; Vivianna Van Deerlin; Lauren Elman; Meredith Spindler; Andres Deik; Andrew Siderowf; John Q Trojanowski; Edward B Lee; Murray Grossman; David J Irwin
Journal:  Acta Neuropathol       Date:  2020-08-17       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.